(Q40959047)

reason for preferred rank

25 September 2017

title

Clinical Relevance of the Histopathological Subclassification of Diffuse “Histiocytic” Lymphoma (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

7 April 2023

Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A362206

7 April 2023

author name string

Strauchen JA

1

1 reference

25 September 2017

Young RC

2

1 reference

25 September 2017

DeVita VT Jr

3

1 reference

25 September 2017

Anderson T

4

1 reference

25 September 2017

Fantone JC

5

1 reference

25 September 2017

Berard CW

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 December 1978

1 reference

25 September 2017

21 December 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=362206

full work available at URL

7 April 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197812212992503

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

The New England Journal of Medicine

7 April 2023

published in

1 reference

25 September 2017

volume

299

1 reference

25 September 2017

issue

25

1 reference

25 September 2017

page(s)

1382-1387

1 reference

Nodular Lymphoma — Evidence for Origin from Follicular B Lymphocytes

25 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

7 April 2023

Cancer Treatment Reports

2

61

953

Jaffe

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Immunologic aspects and pathology of the malignant lymphomas

7 April 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Immunologic characterization of human malignant lymphomas

7 April 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Non-hodgkin's lymphomas.A clinicopathologic study comparing two classifications

7 April 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Advanced diffuse histiocytic lymphoma, a potentially curable disease

7 April 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

7 April 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

7 April 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

7 April 2023

Cancer Treatment Reports

10

61

1037

Berard

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

Malignant lymphoma, lymphoblastic

7 April 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197812212992503

7 April 2023

Identifiers

1 reference

25 September 2017

1 reference